Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Identification of a small-molecule entry inhibitor for filoviruses.

Basu A, Li B, Mills DM, Panchal RG, Cardinale SC, Butler MM, Peet NP, Majgier-Baranowska H, Williams JD, Patel I, Moir DT, Bavari S, Ray R, Farzan MR, Rong L, Bowlin TL.

J Virol. 2011 Apr;85(7):3106-19. doi: 10.1128/JVI.01456-10.

2.

Filovirus entry: a novelty in the viral fusion world.

Hunt CL, Lennemann NJ, Maury W.

Viruses. 2012 Feb;4(2):258-75. doi: 10.3390/v4020258. Review.

3.

Development of treatment strategies to combat Ebola and Marburg viruses.

Paragas J, Geisbert TW.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):67-76. Review.

PMID:
16441210
4.

Evasion of interferon responses by Ebola and Marburg viruses.

Basler CF, Amarasinghe GK.

J Interferon Cytokine Res. 2009 Sep;29(9):511-20. doi: 10.1089/jir.2009.0076. Review.

5.

Drug targets in infections with Ebola and Marburg viruses.

Gene OG, Julia BE, Vanessa MR, Victoria WJ, Thomas GW, Lisa HE.

Infect Disord Drug Targets. 2009 Apr;9(2):191-200. Review.

PMID:
19275706
6.

Small molecule inhibitors of ebola virus infection.

Picazo E, Giordanetto F.

Drug Discov Today. 2015 Feb;20(2):277-86. doi: 10.1016/j.drudis.2014.12.010. Review.

PMID:
25532798
7.

Ebola virus (EBOV) infection: Therapeutic strategies.

De Clercq E.

Biochem Pharmacol. 2015 Jan 1;93(1):1-10. doi: 10.1016/j.bcp.2014.11.008. Review.

PMID:
25481298

Supplemental Content

Support Center